Peripheral T-cell apoptosis is not differentially affected by antiretroviral regimens in HIV-infected patients.
Feuth, Thijs
Peripheral T-cell apoptosis is not differentially affected by antiretroviral regimens in HIV-infected patients. [electronic resource] - Antiviral therapy 2013 - 1021-5 p. digital
Publication Type: Journal Article
2040-2058
10.3851/IMP2644 doi
Adenine--analogs & derivatives
Anti-HIV Agents--therapeutic use
Apoptosis--drug effects
CD4-Positive T-Lymphocytes--immunology
CD8-Positive T-Lymphocytes--immunology
Cross-Sectional Studies
Deoxycytidine--analogs & derivatives
Drug Therapy, Combination
Emtricitabine
Female
HIV Infections--drug therapy
HIV Protease Inhibitors--therapeutic use
Humans
Male
Middle Aged
Organophosphonates--therapeutic use
Proto-Oncogene Proteins c-bcl-2--analysis
Reverse Transcriptase Inhibitors--therapeutic use
Tenofovir
Viral Load--drug effects
Peripheral T-cell apoptosis is not differentially affected by antiretroviral regimens in HIV-infected patients. [electronic resource] - Antiviral therapy 2013 - 1021-5 p. digital
Publication Type: Journal Article
2040-2058
10.3851/IMP2644 doi
Adenine--analogs & derivatives
Anti-HIV Agents--therapeutic use
Apoptosis--drug effects
CD4-Positive T-Lymphocytes--immunology
CD8-Positive T-Lymphocytes--immunology
Cross-Sectional Studies
Deoxycytidine--analogs & derivatives
Drug Therapy, Combination
Emtricitabine
Female
HIV Infections--drug therapy
HIV Protease Inhibitors--therapeutic use
Humans
Male
Middle Aged
Organophosphonates--therapeutic use
Proto-Oncogene Proteins c-bcl-2--analysis
Reverse Transcriptase Inhibitors--therapeutic use
Tenofovir
Viral Load--drug effects